Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

AZN hits all endpoints in phase III study for baxdrostat, a first-in-class treatment targeting hard-to-manage hypertension.

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare ...

Learn about the 7 most common mistakes that can alter your blood pressure readings and find out how to measure accurately to ...

Dont wait for symptoms to show up! Learn how regular doctor visits can help detect health issues early and prevent serious ...

The 24-year study of more than 1.2 million children in Denmark found that aluminum exposure didn't raise the risk of autism, asthma, or other chronic diseases. Other science and research news is on ...

‘A higher-than-expected cardio age can predict higher risk of stroke and heart attack, reduced exercise capacity, cognitive ...

The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...

The Mumbai man was told by the hospital that bariatric surgery, when combined with lifestyle changes, can be a life-saving solution for many ...

Health ministry issues directive for public venues to carry cautionary notices aimed at making people 'aware about hidden fats and excess sugar' ...

A multidisciplinary team at a Mumbai hospital has successfully performed a laparoscopic sleeve gastrectomy on a 45-year-old ...

Health ministry issues directive for public venues to carry cautionary notices aimed at making people 'aware about hidden ...